These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 627137)

  • 21. Relationship between plasma level and therapeutic effect of nortriptyline.
    Asberg M; Crönholm B; Sjöqvist F; Tuck D
    Br Med J; 1971 Aug; 3(5770):331-4. PubMed ID: 5558186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of serum nortriptyline and 10-hydroxy-nortriptyline measurements in the depressed elderly: a multicenter pharmacokinetic and pharmacodynamic study.
    Kin NM; Klitgaard N; Nair NP; Amin M; Kragh-Sorensen P; Schwariz G; Ahmed SK; Holm P; Katona C; Stage K
    Neuropsychopharmacology; 1996 Jul; 15(1):1-6. PubMed ID: 8797186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary data on the relationship between nortriptyline plasma level and response in depressed children.
    Geller B; Cooper TB; Chestnut EC; Anker JA; Schluchter MD
    Am J Psychiatry; 1986 Oct; 143(10):1283-6. PubMed ID: 3532829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined pharmacotherapy and psychotherapy in the acute and continuation treatment of elderly patients with recurrent major depression: a preliminary report.
    Reynolds CF; Frank E; Perel JM; Imber SD; Cornes C; Morycz RK; Mazumdar S; Miller MD; Pollock BG; Rifai AH
    Am J Psychiatry; 1992 Dec; 149(12):1687-92. PubMed ID: 1443245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders.
    Corona GL; Pinelli P; Zerbi F; Fenoglio L; Santagostino G; Frattini P; Cucchi ML
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):102-10. PubMed ID: 7393996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma nortriptyline and clinical response in depression.
    Murphy GE; Simons AD; Wetzel RD
    J Affect Disord; 1985; 8(2):123-9. PubMed ID: 3157720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma nortriptyline and clinical response.
    Burrows G; Scoggins BA; Turecek LR; Davies B
    Clin Pharmacol Ther; 1974 Oct; 16(4):639-44. PubMed ID: 4608523
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative efficacy and safety of nortriptyline and fluoxetine in the treatment of major depression: a clinical study.
    Fabre LF; Scharf MB; Itil TM
    J Clin Psychiatry; 1991 Jun; 52 Suppl():62-7. PubMed ID: 2050651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma tricyclic drug levels in amitriptyline-treated depressed patients.
    Robinson DS; Cooper TB; Ravaris CL; Ives JO; Nies A; Bartlett D; Lamborn KR
    Psychopharmacology (Berl); 1979 Jun; 63(3):223-31. PubMed ID: 113807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma nortriptyline levels--relationship to clinical effects.
    Asberg M
    Clin Pharmacol Ther; 1974 Jul; 16(1):215-29. PubMed ID: 4602067
    [No Abstract]   [Full Text] [Related]  

  • 31. Plasma nortriptyline and clinical response.
    Davies B; Burrows G; Scoggins B
    Aust N Z J Psychiatry; 1975 Dec; 9(4):249-53. PubMed ID: 1062986
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose and plasma levels of nortriptyline and chlorpromazine in delusionally depressed adolescents and of nortriptyline in nondelusionally depressed adolescents.
    Geller B; Cooper TB; Farooki ZQ; Chestnut EC
    Am J Psychiatry; 1985 Mar; 142(3):336-8. PubMed ID: 3970271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between plasma levels of nortriptyline and clinical effects.
    Kragh-Sørensen P
    Commun Psychopharmacol; 1978; 2(5):451-6. PubMed ID: 738023
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics and the effects of nortriptyline in geriatric depressed patients.
    Smith RC; Reed K; Leelavathi DE
    Psychopharmacol Bull; 1980 Jul; 16(3):54-7. PubMed ID: 7403404
    [No Abstract]   [Full Text] [Related]  

  • 35. Routine nortriptyline levels in treatment of depression.
    Montgomery SA; Braithwaite RA; Crammer JL
    Br Med J; 1977 Jul; 2(6080):166-7. PubMed ID: 871827
    [No Abstract]   [Full Text] [Related]  

  • 36. Amitriptyline plasma levels and therapeutic response.
    Ziegler VE; Co BT; Taylor JR; Clayton PJ; Biggs JT
    Clin Pharmacol Ther; 1976 Jun; 19(6):795-801. PubMed ID: 773587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nortriptyline treatment of post-stroke depression: a double-blind study.
    Lipsey JR; Robinson RG; Pearlson GD; Rao K; Price TR
    Lancet; 1984 Feb; 1(8372):297-300. PubMed ID: 6141377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma tyrosine/neutral amino acid ratio correlated with clinical response to nortriptyline in endogenously depressed patients.
    Møller SE; Odum K; Kirk L; Bjerre M; Fog-Møller F; Knudsen A
    J Affect Disord; 1985 Nov; 9(3):223-9. PubMed ID: 2934455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two prospective dosing methods for nortriptyline.
    Perry PJ; Browne JL; Alexander B; Tsuang MT; Sherman AD; Dunner FJ
    Clin Pharmacokinet; 1984; 9(6):555-63. PubMed ID: 6509862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.